Pharmacological targeting of Axin2 suppresses cell growth and metastasis in colorectal cancer
- PMID: 37461816
- DOI: 10.1111/bph.16193
Pharmacological targeting of Axin2 suppresses cell growth and metastasis in colorectal cancer
Abstract
Background and purpose: The scaffold molecule Axin2 is constitutively activated in colorectal cancer (CRC) and functions as a potent promoter of CRC behaviour. Pharmacological targeting of Axin2 may therefore exert a therapeutic effect in patients with CRC. Here, we discovered a potent small-molecule inhibitor of Axin2, based on the mechanism by which Axin2 is regulated post-translationally, and investigated its antitumour effects.
Experimental approach: Compound discovery and its inhibitory action on Axin2 protein were revealed by microscale thermophoresis, in vitro kinase assay, quantitative kinetic assay, immunoblotting/immunoprecipitation, RT-qPCR and cycloheximide pulse-chase assay. Compound antitumour effects and the underlying mechanisms were evaluated in multiple cell-based assays and mouse models.
Key results: We discovered that glycogen synthase kinase 3β (GSK3β) phosphorylates Axin2 at two consensus motifs and coupled Axin2 phosphorylation to its ubiquitination (mediated by the E3 ligase β-Trcp2) and proteasomal degradation. The binding of Axin2 to GSK3β in CRC cells is faint, which enables most of the Axin2 protein to maintain an unphosphorylated status and thereby permits the cells to preserve high levels of Axin2. Importantly, we identified a small-molecule compound CW85319 that enhances Axin2's interaction with GSK3β via forming a high affinity for Axin2. Treatment of CRC cells with CW85319 enhanced Axin2 binding with GSK3β, thereby promoting Axin2 phosphorylation, subsequent ubiquitination, and degradation. Furthermore, we demonstrated that CW85319 efficiently suppressed Axin2-driven CRC growth and metastasis, without eliciting side toxicity.
Conclusions and implications: These findings suggest that pharmacological targeting of Axin2 by CW85319 may provide therapeutic benefits against certain human cancers, especially CRC.
Keywords: GSK3β-Axin2 interaction; Snail; colorectal cancer progression; small-molecule inhibitor; β-Trcp2.
© 2023 British Pharmacological Society.
References
REFERENCES
-
- Alexander, S. P., Kelly, E., Mathie, A., Peters, J. A., Veale, E. L., Armstrong, J. F., Faccenda, E., Harding, S. D., Pawson, A. J., Southan, C., Buneman, O. P., Cidlowski, J. A., Christopoulos, A., Davenport, A. P., Fabbro, D., Spedding, M., Striessnig, J., Davies, J. A., Ahlers-Dannen, K. E., … Zolghadri, Y. (2021). THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: Introduction and other protein targets. British Journal of Pharmacology, 178(S1), S1-S26. https://doi.org/10.1111/bph.15537
-
- Alexander, S. P. H., Roberts, R. E., Broughton, B. R. S., Sobey, C. G., George, C. H., Stanford, S. C., Cirino, G., Docherty, J. R., Giembycz, M. A., Hoyer, D., Insel, P. A., Izzo, A. A., Ji, Y., MacEwan, D. J., Mangum, J., Wonnacott, S., & Ahluwalia, A. (2018). Goals and practicalities of immunoblotting and immunohistochemistry: A guide for submission to the British Journal of Pharmacology. British Journal of Pharmacology, 175(3), 407-411. https://doi.org/10.1111/bph.14112
-
- Bakhoum, S. F., & Cantley, L. C. (2018). The multifaceted role of chromosomal instability in cancer and its microenvironment. Cell, 174(6), 1347-1360. https://doi.org/10.1016/j.cell.2018.08.027
-
- Cha, P.-H., Cho, Y.-H., Lee, S.-K., Lee, J.-H., Jeong, W.-J., Moon, B.-S., Yun, J.-H., Yang, J. S., Choi, S., Yoon, J., Kim, H.-Y., Kim, M.-Y., Kaduwal, S., Lee, W., Min, D. S., Kim, H., Han, G., & Choi, K.-Y. (2016). Small-molecule binding of the axin RGS domain promotes β-catenin and Ras degradation. Nature Chemical Biology, 12(8), 593-600. https://doi.org/10.1038/nchembio.2103
-
- Chen, B., Dodge, M. E., Tang, W., Lu, J., Ma, Z., Fan, C.-W., Wei, S., Hao, W., Kilgore, J., Williams, N. S., Roth, M. G., Amatruda, J. F., Chen, C., & Lum, L. (2009). Small molecule-mediated disruption of Wnt-dependent signaling in tissue regeneration and cancer. Nature Chemical Biology, 5(2), 100-107. https://doi.org/10.1038/nchembio.137
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Research Materials